At meeting held on 28 November 2017
The Board of Vista Pharmaceuticals at its meeting held on 28 November 2017 has approved the allotment of 30 lakh convertible warrants to the promoters and others on preferential basis at an issue price of Rs 50 per warrant.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)